One of the most fascinating periods in the evolution of the human lineage is the appearance of the first ancestors capable of ...

The InvivO2 workstation's numerous cutting-edge features help users examine the most intricate cell interactions in ideal ...

Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

Observational studies have produced mixed findings, with some reporting slower cognitive decline and others not observing any ...

This year's Researcher's Grand Prix was won by Luís Oliveira from Lund University. In Sweden's largest science communication competition for researchers, finalists are judged by the audience and an ...

The advanced FMT assay represents a rapid, high-sensitivity screening solution for anti-fibrotic drug development, providing ...

Researchers Dr. Yuval Hart and Oded Wertheimer from the Psychology department and the Edmond and Lily Safra Center for Brain Science (ELSC) at The Hebrew University of Jerusalem have developed a new ...

The study uncovers genetic factors driving early type 2 diabetes in South Asians, highlighting risks of insulin dependence and medication response challenges.

A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), led by Professor Miguel Ángel del Pozo Barriuso, who heads the Mechanoadaptation and Caveolae Biology group at the CNIC, has ...

New research from Karolinska Institutet shows that long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular ...

Researchers at Uppsala University have analyzed the effects of seven different hormone treatments for menopausal symptoms on the risk of blood clots, stroke and heart attack.